Clorox (CLX) 10-K risk factor changes: FY2021 vs FY2020

Increased purchases of “private label” products [added: or other lower cost priced brands] could reduce net sales of the Company’s higher-margin products or there could be a shift in product mix to lower-margin offerings, which would negatively impact our margins.

The Company’s products generally compete on the basis of product performance, brand [added: reputation and] recognition, [added: image] and price.

In addition, as the Company currently experiences [removed: increased] [added: elevated] demand for many of its products, especially its disinfecting products, [removed: in response to COVID-19,] it expects [added: continued] heightened competitive activity from strong local competitors, other large multinational companies, and new entrants into the market in many of its categories, especially the disinfecting category.

It expects promotional activities to increase as retailers try aggressively to get consumers back into their stores after prolonged “stay at home” and other government restrictions continue to [removed: ease over the coming months.][added: ease.]

[Table of [removed: Contents](#ia45c415f276245979f4403bf4a1f1bef_7)[](#ia45c415f276245979f4403bf4a1f1bef_7)[](#ia45c415f276245979f4403bf4a1f1bef_7)][added: Contents](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)]

The Company’s sales are largely concentrated in the traditional retail grocery, mass retail outlet, warehouse club and dollar store [added: channels, in addition to e-commerce] channels.

However, the retail environment [removed: is continuing] [added: continues] to evolve, and may change to a more significant extent or at a faster pace in light of the COVID-19 pandemic with a greater consumer emphasis on health and wellness, and this could significantly change the way traditional retailers do business.

Alternative retail channels, including [removed: e-commerce retailers,] hard discounters, subscription services and buying clubs, have become more prevalent and [removed: consumers are increasingly purchasing products through such alternative retail channels.][added: popular.]

Further, consumer preferences continue to evolve due to a number of factors, including fragmentation of the consumer market and changes in consumer demographics, which includes the aging of the general population and the emergence of millennial and younger generations who have different spending, consumption and purchasing habits; evolving consumer concerns or perceptions regarding [removed: environmental, social and governance] [added: ESG] practices of manufacturers, including the sourcing and sustainability of packaging materials, such as [removed: plastic packaging;] [added: single-use plastics;] a growing demand for natural or organic products and ingredients; evolving consumer concerns or perceptions (whether accurate or inaccurate) regarding the effects of ingredients or substances present in certain consumer products; and changing consumer sentiment toward non-local products or sources.

If we are not successful in continuing to adapt to changing consumer preferences and market dynamics or expanding sales through e-commerce [removed: retailers, hard discounters and other] [added: retailers or] alternative retail channels, our business, financial condition and results of operations may be negatively impacted.

In addition, [removed: these] [added: e-commerce and] alternative retail channels may create significant pricing pressures for consumer goods, presenting additional challenges to increasing prices in response to commodity or other cost increases in all of the channels into which the Company sells.

[removed: If these] alternative retail channels were to take significant market share away from traditional retailers and/or the Company is not successful in these [removed: alternative retail] channels or business models, our margins and results of operations may be materially and negatively impacted.

The [added: ongoing] COVID-19 [removed: pandemic] [added: pandemic, including the emergence of variants for which vaccines] may [added: not be effective, may] negatively affect our business by causing or contributing to, among other [removed: things, the following:][added: things:]

- [removed: Cessation or significant reductions] [added: Significant disruptions] in [removed: the] [added: our business] operations [removed: of, or the inability, or significant disruptions] [added: and] in the [removed: ability, to meet obligations to us,] [added: ability] of significant third-party [removed: suppliers,] vendors, [removed: external manufacturers] [added: manufacturing] and other business or commercial partners, [removed: which may be caused by their business, operational or financial difficulties, among other reasons.][added: including customers, to meet obligations to us.]

- Significant [removed: decreases in sales of or demand for,] [added: decrease] or [removed: significant] volatility in sales of or demand [removed: for, one or more of] [added: for] our significant products due to, among other [removed: things,] [added: things:] closure or [removed: reduction in] [added: reduced] operating hours of our key customers; [removed: the temporary] [added: consumer] inability [removed: of consumers] to purchase our products due to prolonged inventory shortages, illness or government implemented [removed: lockdowns, quarantine or other restrictions;] [added: restrictions and any resulting] changes in consumer [removed: behavior or preference, including as a result of shortages in any of our products; reductions in the] [added: preference; reduced] availability of [removed: one or more of our] [added: certain] products as we prioritize the production of other products due to increased demand; decreased [removed: availability of our products in the near-term leading to reduced preference or demand for such products in the long term; decreased] future demand due to [added: recent] customer or consumer stockpiling of products [removed: in the present;] [added: or increased consumer mobility as other government restrictions continue to ease;] any negative [added: reputational] impact [removed: to our reputation] resulting from [added: our new partnerships in industries involving shared space or] an adverse perception of our [removed: response to the pandemic,] [added: pandemic response,] perceived price gouging effected [added: or product recommendations made] by third parties that we do not [removed: control or product recommendations by public health officials; the modification by retailers] [added: control; changes in retailer] or [removed: distributors of their] [added: distributor] restocking or fulfillment practices; or [removed: the] worldwide, regional and local adverse [removed: economies] [added: economic] and financial market [removed: conditions.][added: conditions, including increased risk of inflation.]

- [removed: Additional] [added: Significant U.S.] or [removed: renewed significant] [added: international] governmental actions, [removed: both in the U.S. and in international markets where we manufacture, market and sell our products, including lockdowns, quarantines] or other [added: limitations or restrictions, including] restrictions on the ability of our [removed: employees] [added: employees, suppliers, customers or third-party partners] to travel or perform necessary business functions or our ability to manufacture, ship, distribute, market or sell our [removed: products; changes in currency rates and commodity costs associated with governmental actions or general economic trends; or other limitations or restrictions on our ability to manufacture, distribute, market or sell our products or the ability of our suppliers, customers or third-party partners to effectively run their operations, which may negatively impact our ability to manufacture, distribute, market and sell our] products.

In addition, we have experienced higher costs in certain areas as a result of COVID-19 such as transportation and logistics and production employee compensation, as well as incremental costs associated with newly-added health screenings and enhanced cleaning and sanitation protocols to protect our employees at our facilities, which [removed: we expect could continue or could] [added: may continue,] increase [removed: in these] or [removed: could be] [added: become] necessary in [added: these or] other areas.

The extent of COVID-19’s effect on our operational and financial performance [added: in the future] will depend on future developments, including the duration, spread and intensity of the pandemic, our continued ability to manufacture and distribute our products, [removed: as well as] any future government actions affecting consumers and the economy generally, [added: changing economic conditions and any resulting inflationary impacts, as well as timing and effectiveness of global vaccines,] all of which are uncertain and difficult to [removed: predict, especially in light of] [added: predict considering] the rapidly evolving [removed: social and political situations in response to the pandemic.][added: landscape.]

Although the potential effects that COVID-19 may [added: continue to] have on the Company are not clear, such impacts could materially adversely affect the Company’s business, financial condition and results of operations.

Supply chain issues [removed: as a result of a reliance on a limited base of suppliers or the COVID-19 pandemic] may result in product shortages or disruptions to the Company’s business.

The Company [added: also] relies on a [removed: limited] number of [added: sole-source and single-source] suppliers for certain commodities and raw material inputs, including [removed: sole-source and single-source suppliers for certain of its raw materials,] packaging, product components, finished products and other necessary supplies.

The Company [added: also] requires new and existing suppliers to meet its ethical and business partner standards.

The Company could experience material disruptions in production and other supply chain issues, including as a result of supply chain dependencies, which could result in out-of-stock conditions, and its results of operations and relationships with customers could be adversely affected if new or existing suppliers are unable to meet any standards set by the Company, government or industry regulations, or the Company’s customers, if the Company is unable to contract with suppliers at the quantity, quality and price levels needed for its business, if any of the Company’s key suppliers becomes insolvent, ceases or significantly reduces its operations or experiences financial distress, [removed: as a result of the COVID-19 pandemic] or [removed: otherwise, or] if any environmental, [removed: economic or other outside factors impact its operations.]

Net sales to the Company’s largest customer, Walmart Stores, Inc. and its affiliates, were [removed: 25%,] 25% [removed: and 26%] of consolidated net sales for the fiscal years ended June 30, [removed: 2020, 2019] [added: 2021, 2020] and [removed: 2018, respectively,] [added: 2019,] and occurred across all of the Company’s reportable segments.

The Company’s five largest customers accounted for nearly half of the Company’s consolidated net sales for each of the fiscal years [added: 2021,] 2020, [removed: 2019] and [removed: 2018] [added: 2019] and a significant portion of the Company’s future revenues may continue to be derived from a small number of customers.

This trend, which has been magnified due to the COVID-19 pandemic, has resulted in the increased size and influence of large consolidated retailers, who have in the past changed, and may in the future change, their business strategies, demand lower pricing, or higher trade discounts or impose other burdensome requirements on product [removed: suppliers.][added: suppliers or move away from branded products to “private label”.]

Cyber-attacks, privacy breaches, data breaches or a failure of key information technology systems could have a material adverse effect on the Company’s business, financial [removed: condition and] [added: condition,] results of [removed: operation] [added: operations] and [removed: its] reputation.

These systems include, but are not limited to, programs and processes relating to communicating within the Company and with customers, consumers, vendors, investors and other parties; ordering and managing materials from suppliers; converting materials to finished products; receiving and processing purchase orders and shipping products to customers; processing transactions; storing, processing and transmitting data, including personal confidential information and payment card industry data; hosting, processing and sharing confidential and proprietary research, business and financial information; [removed: summarizing] and [removed: reporting results of operations;] complying with financial reporting, regulatory, legal and tax [removed: requirements; and implementing other processes involved in managing the business.][added: requirements.]

Furthermore, the Company sells certain of its Burt’s Bees® natural personal care products, [removed: RenewLife® digestive health products, and Nutranext dietary] [added: vitamins, minerals,] supplements and other products directly to consumers online and through websites, mobile apps and connected devices, and the Company also engages in online activities, including promotions, rebates and customer loyalty and other programs, through which it may receive personal information.

Through the use of any of these information technology systems or processes, the Company or its vendors [added: have in the past and] could [added: in the future again] experience cyber-attacks, privacy breaches, data breaches or other incidents that may result in unauthorized access, disclosure and misuse of consumer, customer, employee, vendor or Company information, especially at a time when a large number of the Company’s employees are working remotely and accessing its technology infrastructure remotely as a result of the COVID-19 pandemic.

The Company [removed: continues to utilize] [added: also utilizes] various [removed: legacy] hardware, software and operating [removed: systems, which] [added: systems that] may [added: need to] be [added: upgraded or replaced in the near future as such system cease to be supported by third-party service providers, and may be] vulnerable to increased risks, including the risk of [added: security breaches,] system failures and disruptions.

If a new system does not function properly, or is not adequately supported by third-party service providers and processes, it could [added: adversely] affect the Company’s [removed: ability to process and deliver customer orders] [added: business] and [removed: process] [added: operations, which, in turn, adversely impact the Company’s results of operations] and [removed: receive payments for its products.][added: cash flows.]

Despite the security measures the Company has in place, the information technology systems, including those of our customers, vendors, suppliers and other third-party service providers with whom we have contracted, [removed: may] [added: have, in the past, and may, in the future,] be vulnerable to cyber-threats such as computer viruses or other malicious codes, security breaches, unauthorized [removed: access attempts,] [added: access,] phishing attacks and other disruptions from employee error, unauthorized uses, system failures, including Internet outages, unintentional or malicious actions of employees or contractors or cyber-attacks by hackers, criminal groups, [removed: nation-state] [added: nationa-states and nation-state-sponsored] organizations [removed: or] [added: and] social-activist organizations.

To date, the [removed: Company’s] [added: Company is not aware that its] business or operations have [removed: not] been materially impacted by these attacks.

However, the [removed: Company cannot guarantee that its] [added: Company’s] security efforts [removed: will] [added: and the efforts of its third-party providers may not] prevent or timely detect attacks and resulting breaches or breakdowns of the Company’s, or its third-party service providers’, databases or systems.

[removed: If] [added: In addition, if] the [removed: systems are damaged] [added: Company] or [removed: cease to function properly due] [added: its third-party providers are unable] to [removed: any number of causes, including catastrophic events, power outages, security breaches, cyber-attacks or other similar events or as a result of legacy systems, and if the Company’s business continuity plans do not] effectively resolve such [removed: issues] [added: breaches or breakdowns] on a timely basis, the Company may experience interruptions in its ability to manage or conduct business, as well as reputational harm, governmental fines, penalties, regulatory proceedings, [added: and] litigation and remediation [removed: expenses, any of which may adversely impact the Company’s business.][added: expenses.]

In addition, such incidents could result in unauthorized disclosure and misuse of material confidential [added: information, including personal] information.

In addition, data breaches or theft of personal information collected by the Company and its third-party service providers as well as [removed: company] [added: Company] information and assets [added: have occurred in the past and] may occur in the future.

The Company is subject to the laws [added: and regulations] of various countries where it operates or does business related to solicitation, collection, processing, transferring, storing or use of consumer, customer, vendor or employee information or related data, including the European Union’s General Data Protection Regulation (“GDPR”), which went into effect in May 2018, and the California Consumer Privacy Act of 2018 (“CCPA”), which went into effect in January 2020.

The changes introduced by [removed: the GDPR] [added: data privacy] and [removed: the CCPA] [added: protection regulations] increase the complexity of regulations enacted to protect business and personal data and they subject the Company to additional costs and have required, and may in the future require, costly changes to the Company’s security systems, policies, procedures and practices.

Business and Industry Risks

If these e-commerce and

Consistent with the ongoing variability in information technology systems industry-wide, our information technology platforms may not be fully compatible at all times with those used by our customers.

Therefore, it may or may not have an impact on our ability to respond to customer demands specific to data or technology.

[Table of Contents](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)

Future acquisitions of foreign companies or new foreign ventures would subject the Company to local regulations and could

[Table of Contents](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)

In addition, to the extent that the economic benefits associated with any of the Company’s acquisitions or investments diminish in the future or the performance of such acquired companies is less robust than expected, the Company may be required to record impairment charges, such as the $329 million pre-tax non-cash impairment charge that the Company recorded during the third quarter of fiscal year 2021, as a result of an adjustment to the carrying values of goodwill, trademarks and other assets in the Better Health Vitamins, Minerals and Supplements (VMS) business.

The Company devotes significant time and resources to training programs, relating to, among other things, ethics, compliance and product safety and quality, as well as sustainability goals, and has published ESG goals, including relating to environmental impact and sustainability and inclusion and diversity, as part of its IGNITE Strategy.

In addition, if sales generated by new

[Table of Contents](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)

The performance of strategic alliances and other business relationships could adversely affect our business, reputation, financial condition and results of operations.

We enter into strategic alliances and other business relationships, such as relationships in connection with the co-development of products or devices, or promotion and sales relationships with companies in industries operating in public spaces.

These relationships may not generate the level of sales we anticipate when entering into the relationship or may otherwise adversely impact our business, reputation, financial condition and results of operations.

Furthermore, such relationships have and, in the future, could create additional exposure to litigation, investigations, disputes or other proceedings, as well as product safety, quality, sustainability and other concerns.

The labor market for these employees is very competitive, and wages and compensation costs continue to increase.

We compete to attract talent within and outside of our industry for high demand skills that are scarce in key geographic areas such as the San Francisco Bay Area.

Related activities to identify, hire and onboard qualified talent at increasing compensation costs may require significant time and expense which could further adversely affect the Company’s operations and financial results.

Operational Risks

The Company has a complex global network of suppliers that has recently expanded to meet increased customer demand and may, in the future, further evolve in response to market conditions.

[Table of Contents](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)

economic or other outside factors impact its operations.

The COVID-19 pandemic has resulted in elevated demand for disinfecting products and other consumer and professional products, as compared to pre-pandemic levels, even though U.S. consumers have begun to adjust their behaviors as vaccination rates have improved.

Any such upgrade could take time, oversight and be costly to the Company.

[Table of Contents](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)

These laws and regulations also may result in the Company incurring additional expenses and liabilities in the event of unauthorized access to or disclosure of personal data.

- continued high levels of inflation in Argentina, which have required and may continue to require, the Company to record gains and losses in net earnings to reflect the remeasurement of the Company's non‐U.S. dollar monetary assets and liabilities of Argentina;

[Table of Contents](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)

markets where chlorine is used in the production of bleach, whether such actions are undertaken by the Company or by the Company’s business partners;

- continuing legal, political and economic uncertainty and disruption from the United Kingdom’s exit from the European Union; and

Legal and Regulatory Risks

Such regulations could negatively impact the Company’s ability to obtain raw materials or could increase its acquisition and compliance costs or cause the company to contribute funds to recycling and other waste management infrastructure, thus making our products more costly, less competitive than other competitive products or reduce consumer demand.

Furthermore, additional or amended legislation in the

[Table of Contents](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)

areas of ESG disclosure or other matters, healthcare reform, sustainability of packaging, including plastic packaging, executive compensation and corporate governance, could also increase the Company’s costs.

The Company is responding to and defending government regulatory inquiries regarding the recall and could be the subject of additional litigation, fines, penalties, or other liability relating to property damage, personal injury, negative publicity, or other losses in connection with the recall.

[Table of Contents](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)

Companies across all industries are facing increasing scrutiny relating to their ESG policies.

Increased focus and activism related to ESG may hinder the Company’s access to capital, as investors may reconsider their capital investment as a result of their assessment of the Company’s ESG practices.

Increased regulatory requirements, including in relation to various aspects of ESG including disclosure requirements, or environmental causes may result in increased compliance or input costs of energy, raw materials or compliance with emissions standards, which may cause disruptions in the manufacture of our products or an increase in operating costs.

In addition, during times of economic uncertainty, consumers may purchase more “private label” or other lower priced brands.

In addition, the growth of the alternative retail channels that are focused on limiting the number of items they sell and selling predominantly “private label” products may reduce the Company’s ability to market and sell its products through such retailers.

In January 2020, the World Health Organization declared the COVID-19 outbreak to be a public health emergency and, in March 2020, it declared the outbreak to be a pandemic.

The COVID-19 outbreak has caused severe global economic and societal disruptions and uncertainties.

In response to the virus, countries and local governments placed tens of millions of people under lockdown, and imposed travel restrictions and restrictions on the operation of non-essential businesses and services.

Companies have also taken precautions, such as requiring employees to work remotely and temporarily closing businesses.

Although some of these restrictions were relaxed, some of those restrictions have been reimposed and the current restrictions, and future prevention and mitigation measures imposed by governments and private companies, are likely to continue to have a severe adverse impact on global economic conditions and consumer confidence and spending.

- Significant disruptions to our manufacturing, distribution and supply operations, including closure of our significant manufacturing and distribution facilities.

- Significant disruptions to our business operations due to, among other things, unavailability of key employees, including our executive officers and senior management team, as a result of illness to themselves or their families; any cyber-attack and other disruptions to informational technologies; cancellation or other disruptions of sales and marketing events; disruptions to trade promotion initiatives; and any delays or modifications to any significant cost savings or other strategic initiatives.

Furthermore, difficult economic conditions may have a negative impact on our ability to access capital markets and other funding sources, on acceptable terms or at all, should we seek any such financing in the future.

We will continue to actively monitor the situation and may take further actions that alter our business operations as may be required by local, state, federal or foreign authorities or that we determine are in the best interests of our employees, consumers, customers or business partners.

The COVID-19 pandemic has caused a significant worldwide increase in demand for disinfecting products and other consumer and professional products.

No other individual customer accounted for 10% or more of the Company’s consolidated net sales in any of these fiscal years.

In addition, some of our customers have experienced, and may experience in the future, declining financial performance, such as in response to the COVID-19 pandemic, which could affect their ability to pay amounts due to us on a timely basis or at all.

These business demands may relate to inventory practices, in-store on online product placement, transportation and storage or product packaging.

Such customers may also shift their focus away from branded products toward “private label” or other aspects of the customer-supplier relationship.

In addition, some of the legacy systems will need to be upgraded or replaced in the future as such systems cease to be supported by third-party service providers.

The Company must also successfully integrate the technology systems of acquired companies into the Company’s existing and future technology systems, including with third-party service providers and processes.

This could adversely impact the Company’s results of operations and cash flows.

In addition, any significant breaches or breakdowns of such database or systems could result in significant costs, including costs to investigate or remediate.

- minimize any potential interruption to the ongoing business of the Company or the acquired company;

- retain key relationships with employees, customers, partners and suppliers of acquired companies;

In addition, to the extent that the economic benefits associated with any of the Company’s acquisitions or investments diminish in the future, whether or not related to the COVID-19 pandemic, the Company may be required to record impairment charges related to goodwill, intangible assets or other assets associated with such transactions, which could adversely affect its financial condition and results of operations.

Unfavorable worldwide, regional and local economic and financial market conditions, including the conditions resulting from the COVID-19 pandemic, may negatively impact the Company and consumers of its products, which would negatively affect the Company’s financial condition, results of operations and cash flow.

The global economy and the economies in regions in which the Company conducts business have experienced substantial economic downturns as a result of the COVID-19 pandemic.

The Company is currently experiencing reduced demand for certain of its consumer products, and may in the future be adversely affected in a material way by lower consumer demand as a result of recessionary economic conditions, including after the direct impact of the COVID-19 pandemic has subsided.

In response to unfavorable economic conditions, including historically high unemployment rates in the U.S., consumers may reduce discretionary spending, which may lead to reduced net sales or cause a shift in the Company’s product mix from higher-margin to lower-margin products.

Consumers may increase purchases of lower-priced or “private label” products, and the Company’s competitors may increase levels of advertising and promotional activity for lower-priced products as they seek to maintain sales volumes during uncertain economic times, which may negatively impact the Company’s net sales.

Global markets continued to face threats and uncertainty during fiscal year 2020.

Future changes to U.S. or foreign tax and trade policies, imposition of new or increased tariffs, other trade restrictions or other government actions, including any government shutdown, foreign currency fluctuations, including devaluations, and fear of exposure to or actual impacts of a widespread disease outbreak, such as the COVID-19 pandemic, may lead to continuation of such risks and uncertainty.

Uncertain economic and financial market conditions may also adversely affect the financial condition of the Company’s customers, suppliers and other business partners.

Any significant decrease in customers’ purchases of the Company’s products or inability of the Company to collect accounts receivable resulting from an adverse impact of the global markets on customers’ financial condition could have a material adverse effect on the Company’s business, financial condition and results of operations.

The Company devotes significant time and resources to training programs that are consistent with our corporate values and are designed to protect and preserve the Company’s reputation and the reputation of its brands and products.

These training programs relate to, among other things, ethics, compliance and product safety and quality, as well as sustainability goals.

Furthermore, additional legislation in the areas of healthcare reform, taxation of domestic and foreign profits, sustainability of packaging, including plastic packaging, executive compensation and corporate governance, could also increase the Company’s costs, any future government shutdowns may result in delays in the acceptance, review and approval of products or claims by the EPA or other governmental agencies, or other required governmental approvals, and any significant tax reform, including any increases in federal, state or local corporate or business tax rates, implemented by the current or future U.S. federal, state or local administrations may adversely affect our business, financial condition and results of operations.

In addition, any additional or renewed significant governmental actions pertaining to the COVID-19 pandemic, including lockdowns, quarantines or other restrictions on the ability of the Company’s employees to travel or perform necessary business functions or its ability to manufacture, distribute, market or sell its products, or the ability of its suppliers, customers or third-party partners to effectively run their operations, may negatively impact the Company’s ability to manufacture, distribute, market and sell its products.

The Company’s efforts to comply with privacy and data protection laws and regulations may impose significant costs and challenges that are likely to increase over time, which could have a material adverse effect on the Company’s financial condition and results of operations.

The Company believes commodity and other cost increases and volatility, especially due to the COVID-19 pandemic, could continue in the future.

- price controls and related government actions;

- continued high levels of inflation in Argentina;

Although the results of claims and litigation cannot be predicted with certainty, based on management’s analysis, it is the opinion of management that the ultimate disposition of these matters, to the extent not previously provided for or disclosed in the [removed: Company’s consolidated financial statements in Exhibit 99.1, will not have a material adverse effect, individually or in the aggregate, on the Company’s consolidated financial statements taken as a whole.]

[Table of Contents](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)

Company’s consolidated financial statements in Exhibit 99.1, will not have a material adverse effect, individually or in the aggregate, on the Company’s consolidated financial statements taken as a whole.

[Table of [removed: Contents](#ia45c415f276245979f4403bf4a1f1bef_7)[](#ia45c415f276245979f4403bf4a1f1bef_7)[](#ia45c415f276245979f4403bf4a1f1bef_7)][added: Contents](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)]

| ☑ | | | Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | | | | | | [removed: | | | | | |]

| | | | for the fiscal year ended | | | June 30, [removed: 2020 | | | | | |] [added: 2021] | | |

| ☐ | | | Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | | | | | | [removed: | | | | | |]

| for the transition period from __________to__________. | | | | | | | | | [removed: | | | | | |]

| | | | Commission file number: | | | 1-07151 | | | [removed: | | | | | |]

| (Address of principal executive offices) (ZIP code) | | | | | | | | | | | | | | | | | | [removed: | | | | | | | | | | | | | | |]

| | | | | | | (510) | | | 271-7000 | | | | | | | | | [removed: | | | | | | | | | | | | | | |]

| (Registrant’s telephone number, including area code) | | | | | | | | | | | | | | | | | | [removed: | | | | | | | | | | | | | | |]

| Securities registered pursuant to Section 12(b) of the Act: | | | | | | | | | | | | | | | | | | [removed: | | | | | | | | | | | | | | |]

| Title of each class | | | | | | [removed: | | |] Trading Symbol(s) | | | | | | [removed: | | |] Name of each exchange on which registered | | | | | | [removed: | | | | | | | | |]

| Common Stock – $1.00 par value | | | | | | [removed: | | |] CLX | | | | | | [removed: | | |] New York Stock Exchange | | | | | | [removed: | | | | | | | | |]

| Securities registered pursuant to Section 12(g) of the Act: | | | | | | | | | | | | | | | | | | [removed: | | | | | | | | | | | | | | |]

| None | | | | | | | | | | | | | | | | | | [removed: | | | | | | | | | | | | | | |]

| (Title of class) | | | | | | | | | | | | | | | | | | [removed: | | | | | | | | | | | | | | |]

The aggregate market value of the registrant’s common stock held by non-affiliates as of December 31, [removed: 2019] [added: 2020] (the last business day of the registrant’s most recently completed second fiscal quarter) was approximately [removed: $19.0] [added: $25.3] billion.

As of July 28, [removed: 2020,] [added: 2021,] there were [removed: 126,213,551] [added: 122,813,075] shares of the registrant’s common stock outstanding.

Portions of the registrant’s definitive proxy statement for the [removed: 2020] [added: 2021] Annual Meeting of Stockholders (the “Proxy Statement”), to be filed within 120 days after June 30, [removed: 2020,] [added: 2021,] are incorporated by reference into Part III, Items 10 through 14 of this Annual Report on Form 10-K.

FOR THE FISCAL YEAR ENDED JUNE 30, [removed: 2020][added: 2021]

| [Part [removed: I](#ia45c415f276245979f4403bf4a1f1bef_10)] [added: I](#ied67f27a152a4d4c94b6c9d4cbc4a19d_10)] | | | | | | [Item [removed: 1.](#ia45c415f276245979f4403bf4a1f1bef_13)] [added: 1.](#ied67f27a152a4d4c94b6c9d4cbc4a19d_13)] | | | | | | [removed: [Business](#ia45c415f276245979f4403bf4a1f1bef_13)] [added: [Business](#ied67f27a152a4d4c94b6c9d4cbc4a19d_13)] | | | [removed: [1](#ia45c415f276245979f4403bf4a1f1bef_10)] [added: [1](#ied67f27a152a4d4c94b6c9d4cbc4a19d_10)] | | |

| | | | | | | [Item [removed: 1.A.](#ia45c415f276245979f4403bf4a1f1bef_16)] [added: 1.A.](#ied67f27a152a4d4c94b6c9d4cbc4a19d_16)] | | | | | | [Risk [removed: Factors](#ia45c415f276245979f4403bf4a1f1bef_16)] [added: Factors](#ied67f27a152a4d4c94b6c9d4cbc4a19d_16)] | | | [removed: [6](#ia45c415f276245979f4403bf4a1f1bef_16)] [added: [8](#ied67f27a152a4d4c94b6c9d4cbc4a19d_16)] | | |

| | | | | | | [Item [removed: 1.B.](#ia45c415f276245979f4403bf4a1f1bef_19)] [added: 1.B.](#ied67f27a152a4d4c94b6c9d4cbc4a19d_19)] | | | | | | [Unresolved Staff [removed: Comments](#ia45c415f276245979f4403bf4a1f1bef_19)] [added: Comments](#ied67f27a152a4d4c94b6c9d4cbc4a19d_19)] | | | [removed: [24](#ia45c415f276245979f4403bf4a1f1bef_19)] [added: [20](#ied67f27a152a4d4c94b6c9d4cbc4a19d_19)] | | |

| | | | | | | [Item [removed: 2.](#ia45c415f276245979f4403bf4a1f1bef_22)] [added: 2.](#ied67f27a152a4d4c94b6c9d4cbc4a19d_22)] | | | | | | [removed: [Properties](#ia45c415f276245979f4403bf4a1f1bef_22)] [added: [Properties](#ied67f27a152a4d4c94b6c9d4cbc4a19d_22)] | | | [removed: [24](#ia45c415f276245979f4403bf4a1f1bef_22)] [added: [20](#ied67f27a152a4d4c94b6c9d4cbc4a19d_22)] | | |

| | | | | | | [Item [removed: 3.](#ia45c415f276245979f4403bf4a1f1bef_25)] [added: 3.](#ied67f27a152a4d4c94b6c9d4cbc4a19d_25)] | | | | | | [Legal [removed: Proceedings](#ia45c415f276245979f4403bf4a1f1bef_25)] [added: Proceedings](#ied67f27a152a4d4c94b6c9d4cbc4a19d_25)] | | | [removed: [24](#ia45c415f276245979f4403bf4a1f1bef_25)] [added: [20](#ied67f27a152a4d4c94b6c9d4cbc4a19d_25)] | | |

| | | | | | | [Item [removed: 4.](#ia45c415f276245979f4403bf4a1f1bef_28)] [added: 4.](#ied67f27a152a4d4c94b6c9d4cbc4a19d_28)] | | | | | | [Mine Safety [removed: Disclosures](#ia45c415f276245979f4403bf4a1f1bef_28)] [added: Disclosures](#ied67f27a152a4d4c94b6c9d4cbc4a19d_28)] | | | [removed: [24](#ia45c415f276245979f4403bf4a1f1bef_28)] [added: [21](#ied67f27a152a4d4c94b6c9d4cbc4a19d_28)] | | |

| [Part [removed: II](#ia45c415f276245979f4403bf4a1f1bef_31)] [added: II](#ied67f27a152a4d4c94b6c9d4cbc4a19d_31)] | | | | | | [Item [removed: 5.](#ia45c415f276245979f4403bf4a1f1bef_34)] [added: 5.](#ied67f27a152a4d4c94b6c9d4cbc4a19d_34)] | | | | | | [Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity [removed: Securities](#ia45c415f276245979f4403bf4a1f1bef_34)] [added: Securities](#ied67f27a152a4d4c94b6c9d4cbc4a19d_34)] | | | [removed: [27](#ia45c415f276245979f4403bf4a1f1bef_34)] [added: [23](#ied67f27a152a4d4c94b6c9d4cbc4a19d_34)] | | |

| | | | | | | [Item [removed: 6.](#ia45c415f276245979f4403bf4a1f1bef_37)] [added: 6.](#ied67f27a152a4d4c94b6c9d4cbc4a19d_37)] | | | | | | [Selected Financial [removed: Data](#ia45c415f276245979f4403bf4a1f1bef_37)] [added: Data](#ied67f27a152a4d4c94b6c9d4cbc4a19d_37)] | | | [removed: [27](#ia45c415f276245979f4403bf4a1f1bef_37)] [added: [23](#ied67f27a152a4d4c94b6c9d4cbc4a19d_37)] | | |

| | | | | | | [Item [removed: 7.](#ia45c415f276245979f4403bf4a1f1bef_40)] [added: 7.](#ied67f27a152a4d4c94b6c9d4cbc4a19d_40)] | | | | | | [Management’s Discussion and Analysis of Financial Condition and Results of [removed: Operations](#ia45c415f276245979f4403bf4a1f1bef_40)] [added: Operations](#ied67f27a152a4d4c94b6c9d4cbc4a19d_40)] | | | [removed: [28](#ia45c415f276245979f4403bf4a1f1bef_40)] [added: [23](#ied67f27a152a4d4c94b6c9d4cbc4a19d_40)] | | |

| | | | | | | [Item [removed: 7.A.](#ia45c415f276245979f4403bf4a1f1bef_43)] [added: 7.A.](#ied67f27a152a4d4c94b6c9d4cbc4a19d_43)] | | | | | | [Quantitative and Qualitative Disclosures About Market [removed: Risk](#ia45c415f276245979f4403bf4a1f1bef_43)] [added: Risk](#ied67f27a152a4d4c94b6c9d4cbc4a19d_43)] | | | [removed: [28](#ia45c415f276245979f4403bf4a1f1bef_43)] [added: [23](#ied67f27a152a4d4c94b6c9d4cbc4a19d_43)] | | |

| | | | | | | [Item [removed: 8.](#ia45c415f276245979f4403bf4a1f1bef_46)] [added: 8.](#ied67f27a152a4d4c94b6c9d4cbc4a19d_46)] | | | | | | [Financial Statements and Supplementary [removed: Data](#ia45c415f276245979f4403bf4a1f1bef_46)] [added: Data](#ied67f27a152a4d4c94b6c9d4cbc4a19d_46)] | | | [removed: [28](#ia45c415f276245979f4403bf4a1f1bef_46)] [added: [23](#ied67f27a152a4d4c94b6c9d4cbc4a19d_46)] | | |

| | | | | | | [Item [removed: 9.](#ia45c415f276245979f4403bf4a1f1bef_49)] [added: 9.](#ied67f27a152a4d4c94b6c9d4cbc4a19d_49)] | | | | | | [Changes in and Disagreements with Accountants on Accounting and Financial [removed: Disclosure](#ia45c415f276245979f4403bf4a1f1bef_49)] [added: Disclosure](#ied67f27a152a4d4c94b6c9d4cbc4a19d_49)] | | | [removed: [28](#ia45c415f276245979f4403bf4a1f1bef_49)] [added: [24](#ied67f27a152a4d4c94b6c9d4cbc4a19d_49)] | | |

| | | | | | | [Item [removed: 9.A.](#ia45c415f276245979f4403bf4a1f1bef_52)] [added: 9.A.](#ied67f27a152a4d4c94b6c9d4cbc4a19d_52)] | | | | | | [Controls and [removed: Procedures](#ia45c415f276245979f4403bf4a1f1bef_52)] [added: Procedures](#ied67f27a152a4d4c94b6c9d4cbc4a19d_52)] | | | [removed: [28](#ia45c415f276245979f4403bf4a1f1bef_52)] [added: [24](#ied67f27a152a4d4c94b6c9d4cbc4a19d_52)] | | |

| | | | | | | [Item [removed: 9.B.](#ia45c415f276245979f4403bf4a1f1bef_55)] [added: 9.B.](#ied67f27a152a4d4c94b6c9d4cbc4a19d_55)] | | | | | | [Other [removed: Information](#ia45c415f276245979f4403bf4a1f1bef_55)] [added: Information](#ied67f27a152a4d4c94b6c9d4cbc4a19d_55)] | | | [removed: [28](#ia45c415f276245979f4403bf4a1f1bef_55)] [added: [24](#ied67f27a152a4d4c94b6c9d4cbc4a19d_55)] | | |

| [Part [removed: III](#ia45c415f276245979f4403bf4a1f1bef_58)] [added: III](#ied67f27a152a4d4c94b6c9d4cbc4a19d_58)] | | | | | | [Item [removed: 10.](#ia45c415f276245979f4403bf4a1f1bef_61)] [added: 10.](#ied67f27a152a4d4c94b6c9d4cbc4a19d_61)] | | | | | | [Directors, Executive Officers and Corporate [removed: Governance](#ia45c415f276245979f4403bf4a1f1bef_61)] [added: Governance](#ied67f27a152a4d4c94b6c9d4cbc4a19d_61)] | | | [removed: [29](#ia45c415f276245979f4403bf4a1f1bef_61)] [added: [25](#ied67f27a152a4d4c94b6c9d4cbc4a19d_61)] | | |

| | | | | | | [Item [removed: 11.](#ia45c415f276245979f4403bf4a1f1bef_64)] [added: 11.](#ied67f27a152a4d4c94b6c9d4cbc4a19d_64)] | | | | | | [Executive [removed: Compensation](#ia45c415f276245979f4403bf4a1f1bef_64)] [added: Compensation](#ied67f27a152a4d4c94b6c9d4cbc4a19d_64)] | | | [removed: [29](#ia45c415f276245979f4403bf4a1f1bef_64)] [added: [25](#ied67f27a152a4d4c94b6c9d4cbc4a19d_64)] | | |

| | | | | | | [Item [removed: 12.](#ia45c415f276245979f4403bf4a1f1bef_67)] [added: 12.](#ied67f27a152a4d4c94b6c9d4cbc4a19d_67)] | | | | | | [Security Ownership of Certain Beneficial Owners and Management and Related Stockholder [removed: Matters](#ia45c415f276245979f4403bf4a1f1bef_67)] [added: Matters](#ied67f27a152a4d4c94b6c9d4cbc4a19d_67)] | | | [removed: [29](#ia45c415f276245979f4403bf4a1f1bef_67)] [added: [25](#ied67f27a152a4d4c94b6c9d4cbc4a19d_67)] | | |

| | | | | | | [Item [removed: 13.](#ia45c415f276245979f4403bf4a1f1bef_70)] [added: 13.](#ied67f27a152a4d4c94b6c9d4cbc4a19d_70)] | | | | | | [Certain Relationships and Related Transactions, and Director [removed: Independence](#ia45c415f276245979f4403bf4a1f1bef_70)] [added: Independence](#ied67f27a152a4d4c94b6c9d4cbc4a19d_70)] | | | [removed: [29](#ia45c415f276245979f4403bf4a1f1bef_70)] [added: [25](#ied67f27a152a4d4c94b6c9d4cbc4a19d_70)] | | |

| | | | | | | [Item [removed: 14.](#ia45c415f276245979f4403bf4a1f1bef_73)] [added: 14.](#ied67f27a152a4d4c94b6c9d4cbc4a19d_73)] | | | | | | [Principal Accounting Fees and [removed: Services](#ia45c415f276245979f4403bf4a1f1bef_73)] [added: Services](#ied67f27a152a4d4c94b6c9d4cbc4a19d_73)] | | | [removed: [29](#ia45c415f276245979f4403bf4a1f1bef_73)] [added: [25](#ied67f27a152a4d4c94b6c9d4cbc4a19d_73)] | | |

| [Part [removed: IV](#ia45c415f276245979f4403bf4a1f1bef_76)] [added: IV](#ied67f27a152a4d4c94b6c9d4cbc4a19d_76)] | | | | | | [Item [removed: 15.](#ia45c415f276245979f4403bf4a1f1bef_79)] [added: 15.](#ied67f27a152a4d4c94b6c9d4cbc4a19d_79)] | | | | | | [Exhibits and Financial Statement [removed: Schedules](#ia45c415f276245979f4403bf4a1f1bef_79)] [added: Schedules](#ied67f27a152a4d4c94b6c9d4cbc4a19d_79)] | | | [removed: [30](#ia45c415f276245979f4403bf4a1f1bef_79)] [added: [26](#ied67f27a152a4d4c94b6c9d4cbc4a19d_79)] | | |

| | | | | | | [Item [removed: 16.](#ia45c415f276245979f4403bf4a1f1bef_82)] [added: 16.](#ied67f27a152a4d4c94b6c9d4cbc4a19d_82)] | | | | | | [Form 10-K [removed: Summary](#ia45c415f276245979f4403bf4a1f1bef_82)] [added: Summary](#ied67f27a152a4d4c94b6c9d4cbc4a19d_82)] | | | [removed: [33](#ia45c415f276245979f4403bf4a1f1bef_82)] [added: [30](#ied67f27a152a4d4c94b6c9d4cbc4a19d_82)] | | |

| | | | | | | | | |

| OR | | | | | | | | |

| | | | | | | | | |

| | | | | | | | | |


| | | | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | | | | | | | | | | | |

| | | | | | | | | | | | | | | | | | |

| | | | | | | | | | | | | | | | | | |

| | | | | | | | | | | | | | | | | | |

| | | | | | | | | | | | | | | | | | |

| | | | | | | | | | | | | | | | | | |

| | | | | | | | | | | | | | | | | | |

| | | | | | | | | | | | | | | | | | |

[Table of Contents](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)

| | | | | | | | | | | | | | | | | | |

| [Signatures](#ied67f27a152a4d4c94b6c9d4cbc4a19d_85) | | | | | | | | | | | | | | | [30](#ied67f27a152a4d4c94b6c9d4cbc4a19d_85) | | |

[Table of Contents](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)

[Table of Contents](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)

Guided by its IGNITE strategy, the Company is well positioned for the future, making significant investments to drive brand loyalty among new and existing consumers.

Clorox is a health and wellness company at heart, putting people at the center of everything it does.

Whether it’s consumers, employees or communities, the Company is committed to helping people be well and thrive every single day.

Clorox fulfills that purpose through its global portfolio by offering products that support people to be safe and well, enable communities to thrive, and bring joy to everyday life at home.

It also prioritizes building a values-based, inclusive workplace culture that celebrates diversity and enables everyone to be their best selves to drive the business.

The emphasis on giving back to the communities where the Company operates is reflected in foundation programs on community wellness, including racial justice, youth development and education, and sustainability; disease prevention; and disaster relief and preparedness.

The Company launched new products in many categories in fiscal year 2021, including Clorox disinfecting wet mopping cloths; Clorox disinfecting all-purpose spray cleaner; Clorox Turbo handheld power sprayers; Clorox TurboPro disinfectant cleaners; Glad with Clorox trash bags; Kingsford wood pellets; Brita Longlast+ water filters; Brita water bottles in new colors; Fresh Step with Gain original scent cat litter with the power of Febreze; Fresh Step Clean Paws Simply Unscented cat litter; Hidden Valley Secret Sauce golden flavor; Hidden Valley Original Ranch Plant Powered topping and dressing; and Burt's Bees Squeezy tinted balm.

Production of some recent innovation that had been temporarily suspended during the pandemic, such as Clorox compostable cleaning wipes and Clorox Scentiva products, were relaunched toward the end of the fiscal year.

Supported by a dedicated supply chain, Clorox expanded its disinfecting wipes business geographically in international markets during fiscal year 2021.

Finally, in fiscal year 2021, Clorox continued to make progress on its environmental, social and governance (ESG) goals that are integrated into the IGNITE strategy and throughout the business.

Notably, the Company achieved 100% renewable electricity for U.S. and Canada operations in January 2021 – four years earlier than initially planned.

Efforts to reduce packaging waste, promote product stewardship, support employee and consumer well-being, and drive inclusion and diversity also made meaningful advancements, while several brands also announced their own sustainability goals.

Clorox also became a signatory to the Ellen MacArthur Foundation's New Plastics Economy Global Commitment.

The Company has been broadly recognized for its corporate responsibility efforts, included on the Barron’s 2020 100 Most Sustainable Companies list, 2021

[Table of Contents](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)

Bloomberg Gender-Equality Index, the Human Rights Campaign’s 2021 Corporate Equality Index and the 2021 Parity.org Best Places for Women to Advance list, among others.

As announced in August 2021, a significant long-term investment in digital capabilities and productivity enhancements will shape the Company’s outlook for fiscal year 2022 and beyond.

Clorox plans to invest approximately $500 million over the next five years, including about $90 million in fiscal year 2022, on these operating and capital expenditures.

The savings realized from the program will generate efficiencies and better position the Company in supply chain, digital commerce, innovation and brand building over the long term.

[Table of Contents](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)

| | | | | | | | | | | | | | | |

| OR | | | | | | | | | | | | | | |

| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| [Signatures](#ia45c415f276245979f4403bf4a1f1bef_85) | | | | | | | | | | | | | | | [34](#ia45c415f276245979f4403bf4a1f1bef_85) | | |

In response, the Company has been taking a pro-active role in addressing the impact of the pandemic on its employees, operations, customers and consumers, including taking precautionary measures, such as implementing contingency plans, and making operational adjustments where necessary.

COVID-19 and the responses of governments, consumers and others to the pandemic have affected and will continue to affect the business in many ways; however, the Company believes that the actions that it is taking will help it emerge from this global pandemic operationally sound and well positioned for continued long-term growth.

The Company also continued its long-standing tradition of helping communities in times of natural disasters and health crises.

The Company launched new products in many categories in fiscal year 2020, including the Brita® Longlast small-capacity pitcher; Burt’s Bees® lip balm in new watermelon and hemp flavors; Burt’s Bees® lip butters; Burt’s Bees® Renewal skin care line with Bakuchiol, a retinol alternative; Clorox® Fabric and Laundry Sanitizer; Clorox® compostable cleaning wipes; Fresh Step® with Febreze Freshness with Gain scent; Glad® Flex-N-Seal food storage bags; Fresh Step® Clean Paws® with Febreze Freshness with Gain scent; Glad® Flex-N-Seal food storage bags; Glad® ForceFlex Plus colorful trash bags in Sweet Citron & Lime and Beachside Breeze with scent-release technology; Hidden Valley® Ranch Secret Sauce in three offerings - Original Ranch, Spicy, and Smokehouse; Kingsford® 100% Hardwood Pellets in five offerings - Classic, Hickory, Maple, Cherry, and Signature; Natural Vitality® Calm Sleep Gummies; Natural Vitality® Calm Sleep Capsules; Neocell® Beauty Shield™ Collagen Gummies; Neocell® Glam Hair & Nails Collagen Gummies; Rainbow Light® Multi Vitamin Gummies for men, women, teens and kids; and Renew Life® Herholistic Probiotics for Period, Prenatal and Menopause.

Finally, in fiscal year 2020, the Company demonstrated its commitment to corporate responsibility by maintaining strong and transparent ESG practices.

As part of its 2020 sustainability goals, the Company continued to work to reduce water and energy use, solid waste to landfill and greenhouse gas emissions as well as improve the sustainability of its product portfolio.

The Company surpassed nearly all its public sustainability goals two years early, and all other areas remained on track.

The Company’s achievements were acknowledged through multiple external recognitions, including Barron’s 100 Most Sustainable Companies in America, Forbes Magazine’s list of America’s best employers for diversity 2020, Newsweek’s 2020 list of America’s 300 Most Responsible Companies, Drucker Institute’s 2019 Management Top 250 list, and Forbes’ and Just Capital’s The Just 100 ranking of America’s best corporate citizens.

Clorox also earned a 100% score on the Human Rights Campaign’s 2020 Corporate Equality Index.

In the fourth quarter of fiscal year 2020, the Company realigned its reportable segments following operational and systems integration.

The Digestive Health and Dietary Supplements SBUs, previously included in the Household and Lifestyle reportable segments, respectively, were combined into a new Vitamins, Minerals and Supplements SBU, and the Home Care and Laundry SBUs, previously included in the Cleaning reportable segment, were combined to create the Cleaning SBU.

These newly established SBUs, along with the Professional Products SBU, now make up the new Health and Wellness reportable segment due to their shared economic and qualitative characteristics.

All periods presented have been recast to reflect this change.

| Grilling products | | | 8 | | % | | | | 9 | | % | | | | 10 | | % |

Costs for resin and other commodity costs decreased in fiscal year 2020, primarily due to volatility as a result of the COVID-19 pandemic, and the Company expects the volatility of commodity and other costs to continue in fiscal year 2021.

The COVID-19 pandemic has caused a significant worldwide increase in demand for disinfecting products and other consumer and professional products.

This has caused strain on the Company’s supply chain network and its ability to meet such demand.

Number of Persons Employed

As of June 30, 2020, the Company employed approximately 8,800 people.

The names, ages, year first elected and current titles of each of the executive officers of the Company as of August [removed: 13, 2020,] [added: 10, 2021,] are set forth below:

| Linda Rendle | | | [removed: 42] [added: 43] | | | 2016 | | | [removed: President] [added: Chief Executive Officer] | | |

| Kevin B. Jacobsen | | | [removed: 54] [added: 55] | | | 2018 | | | Executive Vice President – Chief Financial Officer | | |

| Kirsten Marriner | | | [removed: 47] [added: 48] | | | 2016 | | | Executive Vice President – Chief People [added: and Corporate Affairs] Officer | | |

| Eric Reynolds | | | [removed: 50] [added: 51] | | | 2015 | | | Executive Vice President – [removed: Household and Lifestyle] [added: Chief Operating Officer] | | |

| Chau Banks | | | [removed: 51] [added: 52] | | | 2020 | | | Senior Vice President [removed: -] [added: –] Chief Information [added: and Enterprise Analytics] Officer | | |

| Diego J. Barral | | | [removed: 50] [added: 51] | | | 2018 | | | Senior Vice President – General Manager, International Division | | |

| Troy Datcher | | | [removed: 52] [added: 53] | | | 2019 | | | Senior Vice President – Chief Customer Officer | | |

| Stacey Grier | | | [removed: 57] [added: 58] | | | 2019 | | | Senior Vice President – Chief Marketing [added: and Strategy] Officer | | |

| [removed: Andrew J. Mowery] [added: Rick McDonald] | | | [removed: 54] [added: 61] | | | [removed: 2018] [added: 2020] | | | Senior Vice President – Chief Product Supply Officer | | |

[Table of [removed: Contents](#ia45c415f276245979f4403bf4a1f1bef_7)[](#ia45c415f276245979f4403bf4a1f1bef_7)[](#ia45c415f276245979f4403bf4a1f1bef_7)][added: Contents](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)]

[removed: He] [added: Linda Rendle] is [removed: currently] the [removed: chair and] chief executive officer of the Company, a position [removed: he] [added: she] has held since [removed: August 2016.][added: September 2020.]

Mr. [removed: Dorer] [added: Matta] joined the Company in [removed: 2005.][added: 2020.]

[removed: She] [added: Angela Hilt] is [removed: currently] the [added: senior vice] president [added: – chief legal officer] of the Company, a position she has held since [removed: May] [added: December] 2020.

[removed: Prior to this role, she] [added: She] served as executive vice president – cleaning, international, strategy and operations from July 2019 to May 2020.

Jacobsen is the executive vice president – chief financial officer of the Company, [removed: having served as executive vice president] [added: a position he has held] since January 2019.

Kirsten Marriner is the executive vice president – chief people [added: and corporate affairs] officer of the Company, [removed: having served as executive vice president] [added: a position she has held] since [removed: January 2019.][added: December 2020.]

[removed: Effective September 14, 2020,] Eric Reynolds [removed: will be appointed] [added: is the] executive vice president - chief operating officer of the [removed: Company.][added: Company, a position he has held since September 2020.]

[removed: He] [added: Tony Matta] is [removed: currently] the executive vice president [removed: - household and lifestyle] [added: – chief growth officer] of the Company, a position he has held since [removed: July 2019.][added: October 2020.]

[removed: Prior to this role, he] [added: He] served as executive vice president – cleaning and Burt’s Bees from January 2019 to July 2019.

Chau Banks is the senior vice president – chief information [added: and enterprise analytics] officer of the Company, a position she has held since June [added: 2020, having taken on responsibility for enterprise analytics since September] 2020.

Mr. [removed: Costello] [added: McDonald] joined the Company in [removed: 1988.][added: 1992.]

Stacey Grier is the senior vice president – chief marketing [added: and strategy] officer of the Company, a position she has held since January [removed: 2019.][added: 2019, having taken on responsibility for enterprise strategy since September 2020.]

[removed: Mowery] [added: Rick McDonald] is the senior vice president [removed: –] [added: -] chief product supply officer of the Company, a position he has held since December [removed: 2017.][added: 2020.]

Prior to this role, he served as vice president [removed: – product supply] [added: - global] operations from [removed: February 2014] [added: December 2017] to [removed: November 2017.][added: December 2020.]

| Tony Matta | | | 53 | | | 2020 | | | Executive Vice President – Chief Growth Officer | | |

| Angela Hilt | | | 49 | | | 2020 | | | Senior Vice President – Chief Legal Officer | | |

Prior to this role, she served as the president of the Company from May 2020 to September 2020.

She was appointed to executive vice president - chief people officer in January 2019.

Ms. Marriner joined the Company in March 2016.

Prior to joining Clorox, he was president of Nestlé Coffee Partners, a division of Nestlé U.S., from August 2018 to October 2020.

Before joining Nestlé, he served as Starbucks Corporation's president, global channel development from January 2017 to August 2018, and senior vice president and general manager, U.S. CPG business from April 2016 to January 2017.

Previously, he was chief marketing officer at Kraft Foods Canada Inc. from June 2013 to March 2016.

Before joining Kraft, Mr. Matta held

various leadership roles in marketing at PepsiCo and Procter & Gamble in the U.S., U.K. and Canada.

Prior to this role, he served as executive vice president - household and lifestyle of the Company from July 2019 to September 2020.

Prior to this role, she served as vice president – corporate secretary and deputy general counsel from September 2018 to December 2020, and vice president – corporate secretary and associate general counsel from October 2008 to September 2018.

She served as senior corporate counsel from December 2005 to October 2008.

Ms. Hilt joined the Company in 2005.

He served as vice president - integration, international division from May 2013 to November 2017.

Mr. McDonald has held other leadership roles in the Company’s product supply organization, including vice president - global logistics, and vice president – integrator, cleaning division.

[Table of Contents](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)

| Benno Dorer | | | 56 | | | 2009 | | | Chair and Chief Executive Officer | | |

| Laura Stein | | | 58 | | | 2005 | | | Executive Vice President – General Counsel and Corporate Affairs | | |

| William S. Bailey | | | 54 | | | 2016 | | | Senior Vice President - Corporate and Business Development | | |

| Michael R. Costello | | | 54 | | | 2011 | | | Senior Vice President – General Manager, Nutranext and RenewLife | | |

Effective September 14, 2020, Benno Dorer will step down as the chief executive officer of the Company.

He will continue to serve as the executive chair of the Company’s board of directors.

Prior to this role, he served as chief executive officer of the Company from November 2014 until August 2016.

From January 2013 to November 2014, he served as executive vice president – chief operating officer, cleaning, international and corporate strategy.

From March 2011 to December 2012, he served as senior vice president – cleaning division and Canada.

He served as senior vice president – general manager, cleaning division from June 2009 to March 2011.

Prior to joining the Company, he served in various roles at The Procter & Gamble Company.

Effective September 14, 2020, Linda Rendle will be appointed chief executive officer of the Company and elected to the board of directors.

He continues to have responsibility for the digestive health and dietary supplements businesses, which were previously part of the household and lifestyle segments, respectively, and now have been combined into the vitamins, minerals and supplements business.

Laura Stein is the executive vice president – general counsel and corporate affairs of the Company, having served as executive vice president – general counsel since February 2015, and having taken on responsibility for corporate affairs in February 2016.

She served as senior vice president – general counsel from January 2005 to February 2015.

From January 2000 through January 2005, Ms. Stein was senior vice president – general counsel for H.J. Heinz Company.

Immediately prior to that, she spent eight years working for the Company, lastly as its assistant general counsel – regulatory affairs.

William S.

Bailey is the senior vice president – corporate and business development of the Company, a position he has held since January 2016.

Prior to joining the Company, he served as vice president – corporate and business development at TripAdvisor, from June 2012 to January 2016.

He served as vice president – corporate development at Ancestry.com, from June 2011 to June 2012.

From August 2009 to June 2011, he served as vice president – corporate and business development at Check Point Software Technologies Inc.

Michael R.

Costello is the senior vice president – general manager, Nutranext and RenewLife, having taken on responsibility for Nutranext since April 2018 and RenewLife since May 2018.

Prior to this role, he served as senior vice president – international from September 2013 to April 2018.

He served as vice president – general manager, international, from March 2011 to August 2013.

From July 2009 through March 2011, he served as vice president – general manager, Latin America and Europe.

Andrew J.

He served as vice president – global strategic sourcing & supply chain strategy from April 2011 to February 2014.

Mr. Mowery joined the Company as vice president – global strategic sourcing in April 2009.

Prior to joining the Company, he worked in a variety of supply chain roles at Johnson & Johnson from 1988 to 2009.

The number of record holders of the Company’s common stock as of July 28, [removed: 2020,] [added: 2021,] was [removed: 9,947] [added: 9,624] based on information provided by the Company’s transfer agent.

The following table sets forth the purchases of the Company’s securities by the Company and any affiliated purchasers within the meaning of Rule 10b-18(a)(3) (17 CFR 240.10b-18(a)(3)) during the fourth quarter of fiscal year [removed: 2020.][added: 2021.]

(1)All of the shares purchased in [added: May and] June [removed: 2020] [added: 2021] were acquired pursuant to the Company’s [removed: Evergreen] [added: Open-Market] Program.

| April 1 to 30, 2021 | | | — | | | | | | $ | — | | | | | — | | | | | | $1,293 million | | |

| May 1 to 31, 2021 | | | 760,000 | | | | | | 179.41 | | | | | | 760,000 | | | | | | $1,156 million | | |

| June 1 to 30, 2021 | | | 925,726 | | | | | | 176.77 | | | | | | 925,726 | | | | | | $993 million | | |

| | | | 1,685,726 | | | | | | $ | 177.96 | | | | | 1,685,726 | | | | | | | | |

| April 1 to 30, 2020 | | | — | | | | | | $ | — | | | | | — | | | | | | $1,493 million | | |

| May 1 to 31, 2020 | | | — | | | | | | — | | | | | | — | | | | | | $1,493 million | | |

| June 1 to 30, 2020 | | | 107,796 | | | | | | 209.35 | | | | | | 107,796 | | | | | | $1,493 million | | |

| | | | 107,796 | | | | | | $ | 209.35 | | | | | 107,796 | | | | | | | | |

[Table of Contents](#ia45c415f276245979f4403bf4a1f1bef_7)[](#ia45c415f276245979f4403bf4a1f1bef_7)[](#ia45c415f276245979f4403bf4a1f1bef_7)

[Table of Contents](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)

The Company’s independent registered public accounting firm, Ernst & Young, LLP, has audited the effectiveness of the Company’s internal control over financial reporting as of June 30, [removed: 2020.][added: 2021.]

No change in the Company’s internal control over financial reporting occurred during the fourth fiscal quarter of the fiscal year ended June 30, [removed: 2020,] [added: 2021,] that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

[Table of [removed: Contents](#ia45c415f276245979f4403bf4a1f1bef_7)[](#ia45c415f276245979f4403bf4a1f1bef_7)[](#ia45c415f276245979f4403bf4a1f1bef_7)][added: Contents](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)]

[Table of [removed: Contents](#ia45c415f276245979f4403bf4a1f1bef_7)[](#ia45c415f276245979f4403bf4a1f1bef_7)[](#ia45c415f276245979f4403bf4a1f1bef_7)][added: Contents](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)]

Consolidated Statements of Earnings for the fiscal years ended June 30, [removed: 2020, 2019] [added: 2021, 2020] and [removed: 2018.][added: 2019.]

Consolidated Statements of Comprehensive Income for the fiscal years ended June 30, [removed: 2020, 2019] [added: 2021, 2020] and [removed: 2018.][added: 2019.]

Consolidated Balance Sheets as of June 30, [removed: 2020] [added: 2021] and [removed: 2019.][added: 2020.]

Consolidated Statements of Stockholders’ Equity for the fiscal years ended June 30, [removed: 2020, 2019] [added: 2021, 2020] and [removed: 2018.][added: 2019.]

Consolidated Statements of Cash Flows for the fiscal years ended June 30, [removed: 2020, 2019] [added: 2021, 2020] and [removed: 2018.][added: 2019.]

| | | | | | | | | | | | | Incorporated by Reference | | | | | | | | | | | | | | | | | | | | | [removed: | | | | | | | | | | | | | | | | | |]

| Exhibit Number | | | | | | Exhibit Description | | | | | | Form | | | | | | File No. | | | | | | Exhibit | | | | | | Filing Date | | | [removed: | | | | | | | | | | | | | | | | | |]

| [3.1](http://www.sec.gov/Archives/edgar/data/21076/000002107618000011/fy18clxex31.htm) | | | | | | [Restated Certificate of Incorporation.](http://www.sec.gov/Archives/edgar/data/21076/000002107618000011/fy18clxex31.htm) | | | | | | 10-K | | | | | | 001-07151 | | | | | | 3.1 | | | | | | August 14, 2018 | | | [removed: | | | | | | | | | | | | | | | | | |]

| [3.2](http://www.sec.gov/Archives/edgar/data/21076/000120677416007192/clorox3118954-ex32.htm) | | | | | | [Bylaws (amended and restated).](http://www.sec.gov/Archives/edgar/data/21076/000120677416007192/clorox3118954-ex32.htm) | | | | | | 8-K | | | | | | 001-07151 | | | | | | 3.2 | | | | | | September 15, 2016 | | | [removed: | | | | | | | | | | | | | | | | | |]

| [3.3](http://www.sec.gov/Archives/edgar/data/21076/000120677411001563/exhibit3-1.htm) | | | | | | [Certificate of Designations for The Clorox Company Series A Junior Participating Preferred Stock.](http://www.sec.gov/Archives/edgar/data/21076/000120677411001563/exhibit3-1.htm) | | | | | | 8-K | | | | | | 001-07151 | | | | | | 3.1 | | | | | | July 19, 2011 | | | [removed: | | | | | | | | | | | | | | | | | |]

| [4.1](http://www.sec.gov/Archives/edgar/data/21076/000002107604000113/ex41123.htm) | | | | | | [Indenture, dated as of December 3, 2004, between the Company and The Bank of New York Trust Company N.A., as trustee.](http://www.sec.gov/Archives/edgar/data/21076/000002107604000113/ex41123.htm) | | | | | | 8-K | | | | | | 001-07151 | | | | | | 4.1 | | | | | | December 3, 2004 | | | [removed: | | | | | | | | | | | | | | | | | |]

| [4.2](http://www.sec.gov/Archives/edgar/data/21076/000119312514432856/d829578dex41.htm) | | | | | | [Indenture, dated as of October 9, 2007, between the Company and The Bank of New York Trust Company N.A., as trustee.](http://www.sec.gov/Archives/edgar/data/21076/000119312514432856/d829578dex41.htm) | | | | | | S-3ASR | | | | | | 333-200722 | | | | | | 4.1 | | | | | | December 4, 2014 | | | [removed: | | | | | | | | | | | | | | | | | |]

| [4.3](http://www.sec.gov/Archives/edgar/data/21076/000119312514432856/d829578dex42.htm) | | | | | | [First Supplemental Indenture, dated as of November 9, 2009, among the Company, The Bank of New York Trust Company N.A., and Wells Fargo Bank, National Association, as trustee.](http://www.sec.gov/Archives/edgar/data/21076/000119312514432856/d829578dex42.htm) | | | | | | S-3ASR | | | | | | 333-200722 | | | | | | 4.2 | | | | | | December 4, 2014 | | | [removed: | | | | | | | | | | | | | | | | | |]

| [4.4](http://www.sec.gov/Archives/edgar/data/21076/000119312514432856/d829578dex43.htm) | | | | | | [Second Supplemental Indenture, dated as of November 9, 2009, between the Company and Wells Fargo Bank, National Association, as trustee.](http://www.sec.gov/Archives/edgar/data/21076/000119312514432856/d829578dex43.htm) | | | | | | S-3ASR | | | | | | 333-200722 | | | | | | 4.3 | | | | | | December 4, 2014 | | | [removed: | | | | | | | | | | | | | | | | | |]

| [4.5](http://www.sec.gov/Archives/edgar/data/21076/000119312514432856/d829578dex44.htm) | | | | | | [Third Supplemental Indenture, dated as of November 17, 2011, between the company and Wells Fargo Bank, National Association, as trustee.](http://www.sec.gov/Archives/edgar/data/21076/000119312514432856/d829578dex44.htm) | | | | | | S-3ASR | | | | | | 333-200722 | | | | | | 4.4 | | | | | | December 4, 2014 | | | [removed: | | | | | | | | | | | | | | | | | |]

| [4.6](http://www.sec.gov/Archives/edgar/data/21076/000119312514432856/d829578dex45.htm) | | | | | | [Fourth Supplemental Indenture, dated as of September 13, 2012, between the Company and Wells Fargo Bank, National Association, as trustee.](http://www.sec.gov/Archives/edgar/data/21076/000119312514432856/d829578dex45.htm) | | | | | | S-3ASR | | | | | | 333-200722 | | | | | | 4.5 | | | | | | December 4, 2014 | | | [removed: | | | | | | | | | | | | | | | | | |]

| [4.7](http://www.sec.gov/Archives/edgar/data/21076/000119312514437768/d834952dex41.htm) | | | | | | [Fifth Supplemental Indenture, dated as of December 9, 2014, between the Company and Wells Fargo Bank, National Association, as trustee.](http://www.sec.gov/Archives/edgar/data/21076/000119312514437768/d834952dex41.htm) | | | | | | 8-K | | | | | | 001-07151 | | | | | | 4.1 | | | | | | December 9, 2014 | | | [removed: | | | | | | | | | | | | | | | | | |]

| [4.8](http://www.sec.gov/Archives/edgar/data/21076/000119312517297805/d460865dex41.htm) | | | | | | [Sixth Supplemental Indenture, dated as of September 28, 2017, between the Company and Wells Fargo Bank, National Association, as trustee.](http://www.sec.gov/Archives/edgar/data/21076/000119312517297805/d460865dex41.htm) | | | | | | 8-K | | | | | | 001-07151 | | | | | | 4.1 | | | | | | September 28, 2017 | | | [removed: | | | | | | | | | | | | | | | | | |]

| [4.9](http://www.sec.gov/Archives/edgar/data/21076/000119312518157530/d579971dex41.htm) | | | | | | [Seventh Supplemental Indenture, dated as of May 9, 2018, between the Company and Wells Fargo Bank, National Association, as trustee.](http://www.sec.gov/Archives/edgar/data/21076/000119312518157530/d579971dex41.htm) | | | | | | 8-K | | | | | | 001-07151 | | | | | | 4.1 | | | | | | May 9, 2018 | | | [removed: | | | | | | | | | | | | | | | | | |]

[Table of [removed: Contents](#ia45c415f276245979f4403bf4a1f1bef_7)[](#ia45c415f276245979f4403bf4a1f1bef_7)[](#ia45c415f276245979f4403bf4a1f1bef_7)][added: Contents](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)]

| [removed: [4.1](https://www.sec.gov/Archives/edgar/data/21076/000119312520137535/d929558dex41.htm)[0](https://www.sec.gov/Archives/edgar/data/21076/000119312520137535/d929558dex41.htm)] [added: [4.10](https://www.sec.gov/Archives/edgar/data/21076/000119312520137535/d929558dex41.htm)] | | | | | | [Eighth Supplemental Indenture, dated as of May 8, 2020, between the Company and Wells Fargo Bank, National Association, as trustee.](https://www.sec.gov/Archives/edgar/data/21076/000119312520137535/d929558dex41.htm) | | | | | | 8-K | | | | | | 001-07151 | | | | | | 4.1 | | | | | | May 8, 2020 | | | [removed: | | | | | | | | | | | | | | | | | |]

| [4.11](https://www.sec.gov/Archives/edgar/data/21076/000002107619000012/fy19clxex410.htm) | | | | | | [Description of Capital Stock of The Clorox Company](https://www.sec.gov/Archives/edgar/data/21076/000002107619000012/fy19clxex410.htm) | | | | | | 10-K | | | | | | 001-07151 | | | | | | 4.10 | | | | | | August 14, 2019 | | | [removed: | | | | | | | | | | | | | | | | | |]

| [10.1*](http://www.sec.gov/Archives/edgar/data/21076/000119312508100867/dex1055.htm) | | | | | | [The Clorox Company Amended and Restated Independent Directors’ Deferred Compensation Plan, effective as of November 16, 2005, and amended and restated as of February 7, 2008.](http://www.sec.gov/Archives/edgar/data/21076/000119312508100867/dex1055.htm) | | | | | | 10-Q | | | | | | 001-07151 | | | | | | 10.55 | | | | | | May 2, 2008 | | | [removed: | | | | | | | | | | | | | | | | | |]

| [10.2*](http://www.sec.gov/Archives/edgar/data/21076/000002107604000063/ex10x.htm) | | | | | | [The Clorox Company Non-Qualified Deferred Compensation Plan, adopted as of January 1, 1996, and amended and restated as of July 20, 2004.](http://www.sec.gov/Archives/edgar/data/21076/000002107604000063/ex10x.htm) | | | | | | 10-K | | | | | | 001-07151 | | | | | | 10(x) | | | | | | August 27, 2004 | | | [removed: | | | | | | | | | | | | | | | | | |]

| [10.3*](http://www.sec.gov/Archives/edgar/data/21076/000120677416006893/clorox3118951_1-ex103.htm) | | | | | | [Amendment No.1 to The Clorox Company Non-Qualified Deferred Compensation Plan.](http://www.sec.gov/Archives/edgar/data/21076/000120677416006893/clorox3118951_1-ex103.htm) | | | | | | 10-K | | | | | | 001-07151 | | | | | | 10.3 | | | | | | August 16, 2016 | | | [removed: | | | | | | | | | | | | | | | | | |]

| [10.4*](http://www.sec.gov/Archives/edgar/data/21076/000120677414002682/exhibit10-8.htm) | | | | | | [The Clorox Company Annual Incentive Plan, amended and restated as of [removed: September 17, 2013.](http://www.sec.gov/Archives/edgar/data/21076/000120677414002682/exhibit10-8.htm)] [added: February 9, 2021.](https://www.sec.gov/Archives/edgar/data/21076/000002107621000009/clxq3fy21exhibit101.htm)] | | | | | | [removed: 10-K] [added: 10-Q] | | | | | | 001-07151 | | | | | | [removed: 10.8 | | | | | | August 25, 2014 | | | | | | | | | | | |] [added: 10.1] | | | | | | [added: April 30, 2021] | | |

| [removed: [10.5*](http://www.sec.gov/Archives/edgar/data/21076/000120677413000474/exhibit10-1.htm)] [added: [10.1](http://www.sec.gov/Archives/edgar/data/21076/000119312508180293/dex1018.htm)[3](http://www.sec.gov/Archives/edgar/data/21076/000119312508180293/dex1018.htm)[*](http://www.sec.gov/Archives/edgar/data/21076/000119312508180293/dex1018.htm)] | | | | | | [The Clorox Company [added: Amended and Restated] 2005 [removed: Stock Incentive] [added: Nonqualified Deferred Compensation] Plan, [removed: amended and restated as of November 14, 2012.](http://www.sec.gov/Archives/edgar/data/21076/000120677413000474/exhibit10-1.htm)] [added: effective January 1, 2008.](http://www.sec.gov/Archives/edgar/data/21076/000119312508180293/dex1018.htm)] | | | | | | [removed: 10-Q] [added: 10-K] | | | | | | 001-07151 | | | | | | [removed: 10.1 | | | | | | February 5, 2013 | | | | | | | | | | | |] [added: 10.18] | | | | | | [added: August 19, 2008] | | |

| [removed: [10.](http://www.sec.gov/Archives/edgar/data/21076/000002107617000008/clxq1fy18exhibit102.htm)[6](http://www.sec.gov/Archives/edgar/data/21076/000002107617000008/clxq1fy18exhibit102.htm)[*](http://www.sec.gov/Archives/edgar/data/21076/000002107617000008/clxq1fy18exhibit102.htm)] [added: [10.6*](https://www.sec.gov/Archives/edgar/data/21076/000002107618000015/clxq1fy19exhibit102.htm)] | | | | | | [Form of Performance Share Award Agreement under the Company’s 2005 Stock Incentive Plan for awards made in [removed: 2017.](http://www.sec.gov/Archives/edgar/data/21076/000002107617000008/clxq1fy18exhibit102.htm)] [added: 2018](https://www.sec.gov/Archives/edgar/data/21076/000002107618000015/clxq1fy19exhibit102.htm).] | | | | | | 10-Q | | | | | | 001-07151 | | | | | | 10.2 | | | | | | [removed: November 1, 2017 | | | | | | | | | | | | | | | | | |] [added: October 31, 2018] | | |

| [removed: [10.](http://www.sec.gov/Archives/edgar/data/21076/000002107618000015/clxq1fy19exhibit102.htm)[7](http://www.sec.gov/Archives/edgar/data/21076/000002107618000015/clxq1fy19exhibit102.htm)[*](http://www.sec.gov/Archives/edgar/data/21076/000002107618000015/clxq1fy19exhibit102.htm)] [added: [10.](https://www.sec.gov/Archives/edgar/data/21076/000002107619000016/clxq1fy20exhibit101.htm)[7](https://www.sec.gov/Archives/edgar/data/21076/000002107619000016/clxq1fy20exhibit101.htm)[*](https://www.sec.gov/Archives/edgar/data/21076/000002107619000016/clxq1fy20exhibit101.htm)] | | | | | | [Form of Performance Share Award Agreement under the [removed: Company’s] [added: Company's] 2005 Stock Incentive Plan for awards made in [removed: 2018.](http://www.sec.gov/Archives/edgar/data/21076/000002107618000015/clxq1fy19exhibit102.htm)] [added: 2019.](https://www.sec.gov/Archives/edgar/data/21076/000002107619000016/clxq1fy20exhibit101.htm)] | | | | | | 10-Q | | | | | | 001-07151 | | | | | | [removed: 10.2] [added: 10.1] | | | | | | October 31, [removed: 2018 | | | | | | | | | | | | | | | | | |] [added: 2019] | | |

| [removed: [10.8*](https://www.sec.gov/Archives/edgar/data/21076/000002107619000016/clxq1fy20exhibit101.htm)] [added: [10.8*](https://www.sec.gov/Archives/edgar/data/0000021076/000002107620000021/clxq1fy2110qexhibit1041.htm)] | | | | | | [Form of Performance Share Award Agreement under the [removed: Company's] [added: Company’s] 2005 Stock Incentive Plan for awards made in [removed: 2019.](https://www.sec.gov/Archives/edgar/data/21076/000002107619000016/clxq1fy20exhibit101.htm)] [added: 2020](https://www.sec.gov/Archives/edgar/data/0000021076/000002107620000021/clxq1fy2110qexhibit1041.htm).] | | | | | | 10-Q | | | | | | 001-07151 | | | | | | [removed: 10.1 | | | | | | October 31, 2019 | | | | | | | | | | | |] [added: 10.4] | | | | | | [added: November 2, 2020] | | |

| [removed: [10.9*](http://www.sec.gov/Archives/edgar/data/21076/000002107617000008/clxq1fy18exhibit101.htm)] [added: [10.11*](https://www.sec.gov/Archives/edgar/data/0000021076/000002107621000009/clxq3fy21exhibit106.htm)] | | | | | | [Form of Restricted Stock Unit Award Agreement under the [removed: Company’s] [added: Company's] 2005 Stock Incentive [removed: Plan.](http://www.sec.gov/Archives/edgar/data/21076/000002107617000008/clxq1fy18exhibit101.htm)] [added: Plan (Annual Grant).](https://www.sec.gov/Archives/edgar/data/0000021076/000002107621000009/clxq3fy21exhibit106.htm)] | | | | | | 10-Q | | | | | | 001-07151 | | | | | | [removed: 10.1 | | | | | | October 31, 2018 | | | | | | | | | | | |] [added: 10.6] | | | | | | [added: April 30, 2021] | | |

| [removed: [10.10*](http://www.sec.gov/Archives/edgar/data/21076/000002107617000008/clxq1fy18exhibit103.htm)] [added: [10.10*](https://www.sec.gov/Archives/edgar/data/0000021076/000002107621000009/clxq3fy21exhibit104.htm)] | | | | | | [Form of Nonqualified Stock Option Award Agreement under the Company’s 2005 Stock Incentive [removed: Plan.](http://www.sec.gov/Archives/edgar/data/21076/000002107617000008/clxq1fy18exhibit103.htm)] [added: Plan.](https://www.sec.gov/Archives/edgar/data/0000021076/000002107621000009/clxq3fy21exhibit104.htm)] | | | | | | 10-Q | | | | | | 001-07151 | | | | | | [removed: 10.3 | | | | | | November 1, 2017 | | | | | | | | | | | |] [added: 10.4] | | | | | | [added: April 30, 2021] | | |

| [removed: [10.11*](http://www.sec.gov/Archives/edgar/data/21076/000119312508180293/dex1018.htm)] [added: [10.1](http://www.sec.gov/Archives/edgar/data/21076/000120677411001954/exhibit10-18.htm)[4](http://www.sec.gov/Archives/edgar/data/21076/000120677411001954/exhibit10-18.htm)[*](http://www.sec.gov/Archives/edgar/data/21076/000120677411001954/exhibit10-18.htm)] | | | | | | [removed: [The] [added: [Amendment No. 1 to The] Clorox Company Amended and Restated 2005 Nonqualified Deferred Compensation [removed: Plan, effective January 1, 2008.](http://www.sec.gov/Archives/edgar/data/21076/000119312508180293/dex1018.htm)] [added: Plan.](http://www.sec.gov/Archives/edgar/data/21076/000120677411001954/exhibit10-18.htm)] | | | | | | 10-K | | | | | | 001-07151 | | | | | | 10.18 | | | | | | August [removed: 19, 2008 | | | | | | | | | | | | | | | | | |] [added: 26, 2011] | | |

| [removed: [10.12*](http://www.sec.gov/Archives/edgar/data/21076/000120677411001954/exhibit10-18.htm)] [added: [10.1](http://www.sec.gov/Archives/edgar/data/21076/000120677416006893/clorox3118951_1-ex1013.htm)[5](http://www.sec.gov/Archives/edgar/data/21076/000120677416006893/clorox3118951_1-ex1013.htm)[*](http://www.sec.gov/Archives/edgar/data/21076/000120677416006893/clorox3118951_1-ex1013.htm)] | | | | | | [Amendment No. [removed: 1] [added: 2] to The Clorox Company Amended and Restated 2005 Nonqualified Deferred Compensation [removed: Plan.](http://www.sec.gov/Archives/edgar/data/21076/000120677411001954/exhibit10-18.htm)] [added: Plan.](http://www.sec.gov/Archives/edgar/data/21076/000120677416006893/clorox3118951_1-ex1013.htm)] | | | | | | 10-K | | | | | | 001-07151 | | | | | | [removed: 10.18] [added: 10.13] | | | | | | August [removed: 26, 2011 | | | | | | | | | | | | | | | | | |] [added: 16, 2016] | | |

| [removed: [10.13*](http://www.sec.gov/Archives/edgar/data/21076/000120677416006893/clorox3118951_1-ex1013.htm)] [added: [10.2](http://www.sec.gov/Archives/edgar/data/21076/000120677416006893/clorox3118951_1-ex1024.htm)[7](http://www.sec.gov/Archives/edgar/data/21076/000120677416006893/clorox3118951_1-ex1024.htm)[*](http://www.sec.gov/Archives/edgar/data/21076/000120677416006893/clorox3118951_1-ex1024.htm)] | | | | | | [Amendment No. [removed: 2] [added: 1] to The Clorox Company [removed: Amended and Restated 2005] [added: 2011] Nonqualified Deferred Compensation [removed: Plan.](http://www.sec.gov/Archives/edgar/data/21076/000120677416006893/clorox3118951_1-ex1013.htm)] [added: Plan.](http://www.sec.gov/Archives/edgar/data/21076/000120677416006893/clorox3118951_1-ex1024.htm)] | | | | | | 10-K | | | | | | 001-07151 | | | | | | [removed: 10.13] [added: 10.24] | | | | | | August 16, 2016 | | | [removed: | | | | | | | | | | | | | | | | | |]

| [removed: [10.14*](http://www.sec.gov/Archives/edgar/data/21076/000120677409002024/exhibit10-17.htm)] [added: [10.1](http://www.sec.gov/Archives/edgar/data/21076/000120677409002024/exhibit10-17.htm)[6](http://www.sec.gov/Archives/edgar/data/21076/000120677409002024/exhibit10-17.htm)[*](http://www.sec.gov/Archives/edgar/data/21076/000120677409002024/exhibit10-17.htm)] | | | | | | [The Clorox Company Supplemental Executive Retirement Plan, as restated effective January 5, 2005, as revised August 13, 2009.](http://www.sec.gov/Archives/edgar/data/21076/000120677409002024/exhibit10-17.htm) | | | | | | 10-Q | | | | | | 001-07151 | | | | | | 10.17 | | | | | | November 3, 2009 | | | [removed: | | | | | | | | | | | | | | | | | |]

| [removed: [10.15*](http://www.sec.gov/Archives/edgar/data/21076/000120677411002394/exhibit10-21.htm)] [added: [10.1](http://www.sec.gov/Archives/edgar/data/21076/000120677411002394/exhibit10-21.htm)[7](http://www.sec.gov/Archives/edgar/data/21076/000120677411002394/exhibit10-21.htm)[*](http://www.sec.gov/Archives/edgar/data/21076/000120677411002394/exhibit10-21.htm)] | | | | | | [Amendment No. 1 to The Clorox Company Supplemental Executive Retirement Plan, effective as of July 29, 2011.](http://www.sec.gov/Archives/edgar/data/21076/000120677411002394/exhibit10-21.htm) | | | | | | 10-Q | | | | | | 001-07151 | | | | | | 10.21 | | | | | | November 3, 2011 | | | [removed: | | | | | | | | | | | | | | | | | |]

| [removed: [10.16*](http://www.sec.gov/Archives/edgar/data/21076/000120677412004439/exhibit10-2.htm)] [added: [10.1](http://www.sec.gov/Archives/edgar/data/21076/000120677412004439/exhibit10-2.htm)[8](http://www.sec.gov/Archives/edgar/data/21076/000120677412004439/exhibit10-2.htm)[*](http://www.sec.gov/Archives/edgar/data/21076/000120677412004439/exhibit10-2.htm)] | | | | | | [Amendment No. 2 to The Clorox Company Supplemental Executive Retirement Plan, effective as of September 11, 2012.](http://www.sec.gov/Archives/edgar/data/21076/000120677412004439/exhibit10-2.htm) | | | | | | 10-Q | | | | | | 001-07151 | | | | | | 10.2 | | | | | | November 2, 2012 | | | [removed: | | | | | | | | | | | | | | | | | |]

| [removed: [10.17*](http://www.sec.gov/Archives/edgar/data/21076/000002107618000007/clxq3fy18exhibit101.htm)] [added: [10.1](http://www.sec.gov/Archives/edgar/data/21076/000002107618000007/clxq3fy18exhibit101.htm)[9](http://www.sec.gov/Archives/edgar/data/21076/000002107618000007/clxq3fy18exhibit101.htm)[*](http://www.sec.gov/Archives/edgar/data/21076/000002107618000007/clxq3fy18exhibit101.htm)] | | | | | | [Amendment No. 3 to The Clorox Company Supplemental Executive Retirement Plan, effective as of March 28, 2018.](http://www.sec.gov/Archives/edgar/data/21076/000002107618000007/clxq3fy18exhibit101.htm) | | | | | | 10-Q | | | | | | 001-07151 | | | | | | 10.1 | | | | | | May 2, 2018 | | | [removed: | | | | | | | | | | | | | | | | | |]

| [removed: [10.18*](http://www.sec.gov/Archives/edgar/data/21076/000119312508100867/dex1058.htm)] [added: [10.](https://www.sec.gov/Archives/edgar/data/0000021076/000002107621000009/clxq3fy21exhibit102.htm)[20](https://www.sec.gov/Archives/edgar/data/0000021076/000002107621000009/clxq3fy21exhibit102.htm)[*](https://www.sec.gov/Archives/edgar/data/0000021076/000002107621000009/clxq3fy21exhibit102.htm)] | | | | | | [The Clorox Company Executive Incentive Compensation Plan, amended and restated as of February [removed: 7, 2008.](http://www.sec.gov/Archives/edgar/data/21076/000119312508100867/dex1058.htm)] [added: 9, 2021.](https://www.sec.gov/Archives/edgar/data/0000021076/000002107621000009/clxq3fy21exhibit102.htm)] | | | | | | 10-Q | | | | | | 001-07151 | | | | | | [removed: 10.58 | | | | | | May 2, 2008 | | | | | | | | | | | |] [added: 10.2] | | | | | | [added: April 30, 2021] | | |

| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | | | | | | Incorporated by Reference | | | | | | | | | | | | | | | | | | | | |

| Exhibit Number | | | | | | Exhibit Description | | | | | | Form | | | | | | File No. | | | | | | Exhibit | | | | | | Filing Date | | |

| [10.5*](https://www.sec.gov/Archives/edgar/data/21076/000002107621000009/clxq3fy21exhibit103.htm) | | | | | | [The Clorox Company 2005 Stock Incentive Plan, First Amendment and Restatement as of November 14, 2012; Second Amendment and Restatement as of September 22, 2020; Third Amendment and Restatement as of February 9, 2021.](https://www.sec.gov/Archives/edgar/data/21076/000002107621000009/clxq3fy21exhibit103.htm) | | | | | | 10-Q | | | | | | 001-07151 | | | | | | 10.3 | | | | | | April 30, 2021 | | |

| [10.9*](https://www.sec.gov/Archives/edgar/data/0000021076/000002107620000021/clxq1fy2110qexhibit1041.htm) | | | | | | [Form of Performance Share Award Agreement under the Company’s 2005 Stock Incentive Plan](https://www.sec.gov/Archives/edgar/data/0000021076/000002107620000021/clxq1fy2110qexhibit1041.htm) | | | | | | 10-Q | | | | | | 001-07151 | | | | | | 10.5 | | | | | | April 30, 2021 | | |

| [10.12*](https://www.sec.gov/Archives/edgar/data/0000021076/000002107621000009/clxq3fy21exhibit107.htm) | | | | | | [Form of Restricted Stock Unit Award Agreement under the Company's 2005 Stock Incentive Plan (](https://www.sec.gov/Archives/edgar/data/0000021076/000002107621000009/clxq3fy21exhibit107.htm)[Off-Cy](https://www.sec.gov/Archives/edgar/data/0000021076/000002107621000009/clxq3fy21exhibit107.htm)[c](https://www.sec.gov/Archives/edgar/data/0000021076/000002107621000009/clxq3fy21exhibit107.htm)[l](https://www.sec.gov/Archives/edgar/data/0000021076/000002107621000009/clxq3fy21exhibit107.htm)[e](https://www.sec.gov/Archives/edgar/data/0000021076/000002107621000009/clxq3fy21exhibit107.htm) [Grant).](https://www.sec.gov/Archives/edgar/data/0000021076/000002107621000009/clxq3fy21exhibit107.htm) | | | | | | 10-Q | | | | | | 001-07151 | | | | | | 10.7 | | | | | | April 30, 2021 | | |

[Table of Contents](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)

| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | | | | | | Incorporated by Reference | | | | | | | | | | | | | | | | | | | | |

| Exhibit Number | | | | | | Exhibit Description | | | | | | Form | | | | | | File No. | | | | | | Exhibit | | | | | | Filing Date | | |

| [10.34](http://www.sec.gov/Archives/edgar/data/21076/000002107621000004/clxq2fy21exhibit101.htm) | | | | | | [Acknowledgement Letter to the Amended and Restated Joint Venture Agreement, dated as of October 7, 2020, between The Glad Products Company and certain affiliates and The Procter & Gamble Company and certain affiliates.](http://www.sec.gov/Archives/edgar/data/21076/000002107621000004/clxq2fy21exhibit101.htm) | | | | | | 10-Q | | | | | | 001-07151 | | | | | | 10.2 | | | | | | February 4, 2021 | | |

[Table of Contents](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)

| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | | | | | | Incorporated by Reference | | | | | | | | | | | | | | | | | | | | |

| Exhibit Number | | | | | | Exhibit Description | | | | | | Form | | | | | | File No. | | | | | | Exhibit | | | | | | Filing Date | | |

| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| [10.2](http://www.sec.gov/Archives/edgar/data/21076/000120677416006893/clorox3118951_1-ex1024.htm)[5](http://www.sec.gov/Archives/edgar/data/21076/000120677416006893/clorox3118951_1-ex1024.htm)[*](http://www.sec.gov/Archives/edgar/data/21076/000120677416006893/clorox3118951_1-ex1024.htm) | | | | | | [Amendment No. 1 to The Clorox Company 2011 Nonqualified Deferred Compensation Plan.](http://www.sec.gov/Archives/edgar/data/21076/000120677416006893/clorox3118951_1-ex1024.htm) | | | | | | 10-K | | | | | | 001-07151 | | | | | | 10.24 | | | | | | August 16, 2016 | | | | | | | | | | | | | | | | | | | | |

[Table of [removed: Contents](#ia45c415f276245979f4403bf4a1f1bef_7)[](#ia45c415f276245979f4403bf4a1f1bef_7)[](#ia45c415f276245979f4403bf4a1f1bef_7)][added: Contents](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)[](#ied67f27a152a4d4c94b6c9d4cbc4a19d_7)]

| | | | THE CLOROX COMPANY | | | | | | [removed: | | | | | |]

| | | | | | | [removed: Chair and] Chief Executive Officer | | | [removed: | | | | | |]

| /s/ A. Banse | | | | | | Director | | | | | | August [removed: 13, 2020] [added: 10, 2021] | | |

| /s/ R. H. Carmona | | | | | | Director | | | | | | August [removed: 13, 2020] [added: 10, 2021] | | |

| /s/ S. C. Fleischer | | | | | | Director | | | | | | August [removed: 13, 2020] [added: 10, 2021] | | |

| /s/ E. Lee | | | | | | Director | | | | | | August [removed: 13, 2020] [added: 10, 2021] | | |

| /s/ A. D. D. Mackay | | | | | | Director | | | | | | August [removed: 13, 2020] [added: 10, 2021] | | |

| /s/ K. Tesija | | | | | | Director | | | | | | August [removed: 13, 2020] [added: 10, 2021] | | |

| /s/ P. Thomas-Graham | | | | | | Director | | | | | | August [removed: 13, 2020] [added: 10, 2021] | | |

| /s/ R. J. Weiner | | | | | | Director | | | | | | August [removed: 13, 2020] [added: 10, 2021] | | |

| /s/ C. J. Williams | | | | | | Director | | | | | | August [removed: 13, 2020] [added: 10, 2021] | | |

| /s/ [removed: B. Dorer] [added: L. Rendle] | | | | | | [removed: Chair and] Chief Executive Officer (Principal Executive Officer) | | | | | | August [removed: 13, 2020] [added: 10, 2021] | | |

| /s/ K. B. Jacobsen | | | | | | Executive Vice President – Chief Financial Officer (Principal Financial Officer) | | | | | | August [removed: 13, 2020] [added: 10, 2021] | | |

| /s/ [removed: J. R. Baker] [added: L. Peck] | | | | | | Vice President – Chief Accounting Officer and Corporate Controller (Principal Accounting Officer) | | | | | | August [removed: 13, 2020] [added: 10, 2021] | | |

| | | | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | | |

| Date: August 10, 2021 | | | By: | | | /s/ Linda Rendle | | |

| | | | | | | Linda Rendle | | |

| /s/ P. Parker | | | | | | Director | | | | | | August 10, 2021 | | |

| P. Parker | | | | | | | | | | | | | | |

| /s/ M. J. Shattock | | | | | | Independent Chair | | | | | | August 10, 2021 | | |

| L. Rendle | | | | | | | | | | | | | | |

| L. Peck | | | | | | | | | | | | | | |

| | | | | | | | | | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| Date: August 13, 2020 | | | By: | | | /s/ Benno Dorer | | | | | | | | |

| | | | | | | Benno Dorer | | | | | | | | |

| /s/ R. W. Matschullat | | | | | | Director | | | | | | August 13, 2020 | | |

| R. W. Matschullat | | | | | | | | | | | | | | |

| /s/ M. J. Shattock | | | | | | Director | | | | | | August 13, 2020 | | |

| B. Dorer | | | | | | | | | | | | | | |

| J. R. Baker | | | | | | | | | | | | | | |